Novavax Analyst Ratings
B of A Securities Maintains Neutral on Novavax, Raises Price Target to $18
Novavax Analyst Ratings
Novavax Inc.: B. Riley increases target price from $11 to $29
Novavax (NVAX) Was Upgraded to a Hold Rating at J.P. Morgan
TD Cowen raised Novavax Pharmaceuticals price target to $10
TD Cowen: Maintaining the Novavax (NVAX.US) rating, adjusted from holding to holding rating, and adjusting the target price from $5.00 to $10.00.
Novavax Analyst Ratings
Novavax Analyst Ratings
Bank of America sharply raised the target price of Novavax Pharmaceuticals to $12
Novavax Analyst Ratings
B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12
Buy Rating for Novavax Amid Strategic Sanofi Partnership and Solid Financial Prospects
HC Wainwright & Co. Maintains Buy on Novavax, Lowers Price Target to $19
Novavax Analyst Ratings
Maintaining Hold on Novavax: Assessing Current Performance and Future Market Penetration Strategies
Optimizing for Growth: Novavax's Settlement, Cost Reductions, and CIC Vaccine Propel Buy Rating
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Align Tech (ALGN) and Novavax (NVAX)
B. Riley Lowers Novavax's Price Target to $12 From $15 After Near-Term COVID-19 Sales Estimate Revisions, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Verrica Pharmaceuticals (VRCA)